We are live on ! Find out more
AUTL

Autolus Therapeutics
AUTL

63 hedge funds and large institutions have $129M invested in Autolus Therapeutics in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 6

100% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 10

31% more funds holding

Funds holding: 48 → 63 (+15)

15% more capital invested

Capital invested by funds: $113M → $129M (+$16.8M)

9.72% more ownership

Funds ownership: 24.11% → 33.82% (+9.7%)

Holders
63
Holders Change
+15
Holders Change %
+31.25%
% of All Funds
1.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
20
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$15.9M
2
OM
Opaleye Management
Massachusetts
+$15.6M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$14.5M
4
IC
Ikarian Capital
Texas
+$9.3M
5
Capital International Investors
Capital International Investors
California
+$7.77M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$5.1M
2
BBA
Baker Bros. Advisors
New York
-$2.37M
3
EP
Eversept Partners
New York
-$1.39M
4
GIM
Granahan Investment Management
Massachusetts
-$924K
5
Victory Capital Management
Victory Capital Management
Texas
-$541K
Name Holding Trade Value Shares
Change 		Change in
Stake
Capital World Investors
1
Capital World Investors
California
$16.9M – – –
TAM
2
TFG Asset Management
Cayman Islands
$14M +$2.11M +285,714 +13%
Capital International Investors
3
Capital International Investors
California
$13M +$7.77M +1,050,040 +86%
DM
4
Deerfield Management
New York
$12.3M +$15.9M +2,142,857 New
OM
5
Opaleye Management
Massachusetts
$12.1M +$15.6M +2,112,918 New
Fidelity Investments
6
Fidelity Investments
Massachusetts
$11.9M +$14.5M +1,957,721 +1,736%
Schroder Investment Management Group
7
Schroder Investment Management Group
United Kingdom
$9.59M – – –
IC
8
Ikarian Capital
Texas
$7.2M +$9.3M +1,256,048 New
AI
9
Alphabet Inc
California
$4M – – –
JP Morgan Chase
10
JP Morgan Chase
New York
$3.18M +$2.22M +300,109 +118%
SM
11
Sabby Management
Florida
$3.01M +$3.89M +525,230 New
BBA
12
Baker Bros. Advisors
New York
$2.65M -$2.37M -320,457 -41%
CAM
13
Cormorant Asset Management
Massachusetts
$2.42M – – –
GIM
14
Granahan Investment Management
Massachusetts
$1.95M -$924K -124,848 -27%
BlackRock
15
BlackRock
New York
$1.71M -$19.7K -2,655 -0.9%
Millennium Management
16
Millennium Management
New York
$1.31M +$1.46M +197,636 +640%
CCM
17
CAAS Capital Management
New York
$1.28M +$1.65M +223,366 New
Alyeska Investment Group
18
Alyeska Investment Group
Illinois
$1.2M +$318K +42,897 +26%
PG
19
Pendal Group
Australia
$1.05M +$527K +71,211 +141%
LCM
20
Laurion Capital Management
New York
$876K +$1.13M +152,847 New
BFM
21
Boothbay Fund Management
New York
$859K +$1.11M +149,912 New
Morgan Stanley
22
Morgan Stanley
New York
$810K +$89K +12,017 +9%
EAM
23
Erste Asset Management
Austria
$659K +$888K +120,000 New
Marshall Wace
24
Marshall Wace
United Kingdom
$568K +$733K +99,013 New
Squarepoint
25
Squarepoint
New York
$473K +$611K +82,602 New
1
2 3

AUTL Hedge Fund Activity: Q1 2021 in Review

63 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Autolus Therapeutics (AUTL) for Q1 2021, worth a combined $129M — up 15% from $113M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new AUTL positions and 6 closed out — a net gain of 16 holders — while 20 added to existing stakes and 10 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $15.9M. The largest seller was Franklin Resources, exiting entirely with an estimated $5.1M sold.

  • 63 institutional investors held Autolus Therapeutics (AUTL) as of Q1 2021, up from 48 in Q4 2020.
  • Funds reported $129M of Autolus Therapeutics stock for Q1 2021, up 15% quarter-over-quarter.
  • 22 funds opened new Autolus Therapeutics positions in Q1 2021 and 6 closed out, a net change of +16 holders.
  • The largest Autolus Therapeutics buyer in Q1 2021 was Deerfield Management, an estimated $15.9M added.
  • The largest Autolus Therapeutics seller in Q1 2021 was Franklin Resources, an estimated $5.1M sold.

Based on aggregated 13F filings for Q1 2021.